Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Plavix (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 30
» View wsbtradio.com items only
    May 14, 2013 |Story| Reuters
  1. French competition body fines Sanofi in Plavix dispute

    Reuters
    PARIS (Reuters) - The French Competition Authority said on Tuesday it fined drugmaker Sanofi 40.6 million euros ($52.7 million) over what it called a smear campaign aimed at stifling generic competition to its blood thinner, Plavix. The decision...

    Tags: Drugs and Medicines, Clopidogrel (drug), Fines, Teva Pharmaceutical Industries Limited, Punishment

  2. May 12, 2013 |Story| Herald Mail
  3. Shop around for deals on prescription drugs

    If your insurance has ever stopped covering a prescription drug or you don’t have coverage at all, you know how quickly costs can mount. Americans spent, on average, $758 out of pocket for medication in 2012, according to a recent Consumer Reports...

    Tags: Prices, Target, Actos (drug), Pharmaceuticals, Asthma

  4. May 10, 2013 |Story| Reuters
  5. RPT-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices

    Reuters
    (Repeats to widen readership) By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc...

    Tags: Prices, European Parliament, Novartis AG, Science and Technology, Consumers

  6. May 8, 2013 |Story| Reuters
  7. U.S. spending on medicines fell for first time in 2012

    Reuters
    (Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years, according to a report released on Thursday. Overall U.S....

    Tags: Patents, Copyrights and Trademarks, Flu, Patient Protection and Affordable Care Act, AstraZeneca Plc, Bristol Myers Squibb Company

  8. May 10, 2013 |Story| Reuters
  9. XxANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices

    Reuters
    By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and AstraZeneca have grown...

    Tags: European Parliament, Prices, Novartis AG, Science and Technology, Consumers

  10. May 10, 2013 |Story| Reuters
  11. REFILE-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices

    Reuters
    (Removes "XX" from headline) By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and...

    Tags: Prices, European Parliament, Novartis AG, Science and Technology, Consumers

  12. May 9, 2013 |Story| Reuters
  13. Spending on drugs falls for first time in 55 years

    The amount of money Americans spend on prescription drugs fell for the first time in 55 years, according to a report from the IMS Institute of Healthcare Informatic.
    Reuters
    The amount of money Americans spend on prescription drugs fell for the first time in 55 years, according to a report from the IMS Institute of Healthcare Informatic. The expiration of patents on widley used drugs such drugs such as Lipitor and Plaviix...

    Tags: Bristol Myers Squibb Company, Patents, Copyrights and Trademarks, Health Insurance Cost, Prescription Drugs, Lipitor (drug)

  14. May 9, 2013 |Story| Los Angeles Times
  15. Drug spending falls for first time in 6 decades

    An explosion of cheap generic substitutes for widely used prescription drugs last year helped drive the first decline in pharmaceutical spending in the U.S. in nearly six decades.
    An explosion of cheap generic substitutes for widely used prescription drugs last year helped drive the first decline in pharmaceutical spending in the U.S. in nearly six decades. Drug makers often lament what they call the patent cliff, which is when...

    Tags: Patents, Copyrights and Trademarks, Flu, Science and Technology, Prescription Drugs, Pharmaceuticals

  16. May 7, 2013 |Story| KSPR-TV
  17. More people buying prescription drugs overseas online

      The federal government doesn't want you to do it but more and more of you are.  The high cost of prescription drugs has many Americans turning to other countries to make their purchases.  The Food and Drug Administration says that's dangerous. 
    Reporter and Photographer
      The federal government doesn't want you to do it but more and more of you are.  The high cost of prescription drugs has many Americans turning to other countries to make their purchases.  The Food and Drug Administration says that's dangerous.    More...

    Tags: Food and Drug Administration, Prescription Drugs, Pharmaceuticals, Drugs and Medicines, Viagra (drug)

  18. May 2, 2013 |Story| Baltimore Sun
  19. Patients settle stent claims against Midei, St. Joseph

    Nearly 250 of the patients who accused cardiologist Dr. Mark Midei of performing unnecessary stent procedures at St. Joseph Medical Center settled their lawsuits against him Thursday, a major step forward in one of the largest medical malpractice cases in state history.
    Nearly 250 of the patients who accused cardiologist Dr. Mark Midei of performing unnecessary stent procedures at St. Joseph Medical Center settled their lawsuits against him Thursday, a major step forward in one of the largest medical malpractice cases in...

    Tags: Cardiologists, Health and Medical Professionals, Laws, Baltimore County, Litigation

  20. Apr 19, 2013 |Story| Los Angeles Times
  21. Strategies for cutting the cost of prescription drugs

    When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it.
    When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it. The 59-year-...

    Tags: Oncology, Science and Technology, Bevacizumab (drug), Pharmaceuticals, National Institutes of Health

  22. Apr 26, 2013 |Story| Baltimore Sun
  23. Sinai to research new drug to prevent blood clots, heart attacks in stent patients

    A Sinai Hospital cardiologist is launching a clinical trial of a type of coronary artery disease drug not yet tested in humans, building on a history at the Baltimore hospital of research to develop more effective treatments to prevent blood clotting.
    A Sinai Hospital cardiologist is launching a clinical trial of a type of coronary artery disease drug not yet tested in humans, building on a history at the Baltimore hospital of research to develop more effective treatments to prevent blood clotting....

    Tags: University of Maryland, College Park, Cardiologists, Science and Technology, Food and Drug Administration, Pharmaceuticals

 1  2 3Next >
Original site for Plavix (drug) topic gallery.